P/E ratio for Avanos Medical (AVNS)
P/E ratio as of May 2024 (TTM): -16.6
According to Avanos Medical 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -16.563. At the end of 2022 the company had a P/E ratio of 25.1.
P/E ratio history for Avanos Medical from 2014 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 25.1 | -92.05% |
| 2021 | 315 | -491.57% |
| 2020 | -80.5 | 131.68% |
| 2019 | -34.7 | -194.63% |
| 2018 | 36.7 | 33.56% |
| 2017 | 27.5 | -37.56% |
| 2016 | 44.0 | -1305.68% |
| 2015 | -3.65 | -104.69% |
| 2014 | 77.8 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 SINTX Technologies
SINT | -0.0017 | -99.99% | 🇺🇸 USA |
 Sientra SIEN | -0.0261 | -99.84% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.